Ubivac

Developer of dendritic cell (DC)-targeted complex vaccine combination immunotherapy for cancer

placePortland, Oregon, United States calendar_todayFounded 2005 groups5 employees language ubivac.com

Registered entities

Social engagement

Social engagement: 926 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

24 Sep 2025
Event
SITC 2025
Coming soon